AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1354687 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocopherol (0.1 mM)
Number of subjects: 15
Study 1354687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 6499511 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg meptazinol every 3 to 6 hours as required for 72 hours
Number of subjects: 60
Study 6499511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31022368 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake assessed using three 24-hour recalls and scored for HEI-2010
Number of subjects: 170
Study 31022368 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake assessed using three 24-hour recalls and scored for AHEI-P
Number of subjects: 170
Study 31022368 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient intake assessment
Number of subjects: 170
Study 29042063 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine (10 mL)
Number of subjects: 30
Study 29042063 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine (5 mL)
Number of subjects: 30
Study 25833706 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfect adherence (100%)
Number of subjects: 988
Study 25833706 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately high adherence (75-99%)
Number of subjects: 988
Study 25833706 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately low adherence (50-74%)
Number of subjects: 988
Study 25833706 — intervention group
Group type: EXPERIMENTAL
Intervention: Low adherence (<50%)
Number of subjects: 988
Study 24211840 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (10Hz) over the left DLPFC, 110% motor threshold, 20 trains, 10s duration per train, 30s inter-train interval, 21 sessions, total 42,000 pulses
Number of subjects: 35
Study 24211840 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (placebo stimulation)
Number of subjects: 35
Study 23050557 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum CJLP133 (0.5 × 10^10 CFU, twice a day for 12 weeks)
Number of subjects: 118
Study 23050557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 19066606 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-oxo-dG levels in tumor tissue
Number of subjects: 143
Study 19066606 — intervention group
Group type: EXPERIMENTAL
Intervention: Epithelial nuclear and stromal staining in normal mucosa and tumor
Number of subjects: 143
Study 19066606 — intervention group
Group type: COMPARATOR
Intervention: Nuclear staining levels in tumor tissue and matched normal mucosa
Number of subjects: 143
Study 19066606 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-oxo-dG levels with local disease spread
Number of subjects: 143
Study 19066606 — intervention group
Group type: COMPARATOR
Intervention: Normal control cells in tissue from cancer patients with high levels of 8-oxo-dG
Number of subjects: 143
Study 17469752 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrysof Natural IOL
Number of subjects: 30
Study 17469752 — intervention group
Group type: COMPARATOR
Intervention: Standard Acrysof IOL (Control)
Number of subjects: 30
Study 15234224 — intervention group
Group type: EXPERIMENTAL
Intervention: Markov surgical decision analysis
Number of subjects: 206
Study 15234224 — intervention group
Group type: COMPARATOR
Intervention: Standard decision-making
Number of subjects: 206
Study 12361896 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin SR
Number of subjects: 81
Study 12361896 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 9545151 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pharmacist intervention
Number of subjects: 208
Study 9545151 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 208
Study 7715622 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training group
Number of subjects: 16
Study 7715622 — intervention group
Group type: COMPARATOR
Intervention: Natural history (control) group
Number of subjects: 16
Study 2236714 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbotage with isobaric bupivacaine 0.5%
Number of subjects: 60
Study 2236714 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbotage with hyperbaric bupivacaine 0.5%
Number of subjects: 60
Study 2236714 — intervention group
Group type: COMPARATOR
Intervention: No barbotage with isobaric bupivacaine 0.5%
Number of subjects: 60
Study 2236714 — intervention group
Group type: COMPARATOR
Intervention: No barbotage with hyperbaric bupivacaine 0.5%
Number of subjects: 60
Study 35391 — intervention group
Group type: EXPERIMENTAL
Intervention: Quickly dried and exposed to room air (group B)
Number of subjects: 53
Study 35391 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrapped with two towels (group D)
Number of subjects: 53
Study 35391 — intervention group
Group type: EXPERIMENTAL
Intervention: Not dried and exposed wet to room air (group A)
Number of subjects: 53
Study 35391 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed under the radiant heater (group F)
Number of subjects: 53
Study 35391 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrapped with one sterile sheet (group C)
Number of subjects: 53
Study 35391 — intervention group
Group type: EXPERIMENTAL
Intervention: Placed under the radiant heater (group E)
Number of subjects: 53
Study 31350545 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncooperative-group-sponsored trials
Number of subjects: 147
Study 31350545 — intervention group
Group type: COMPARATOR
Intervention: Cooperative group trials
Number of subjects: 147
Study 31066177 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (<120 mm Hg)
Number of subjects: 11784
Study 31066177 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (<140 mm Hg)
Number of subjects: 11784
Study 27584578 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine deprivation with ADI-PEG20 (36.8 mg/m2, weekly intramuscular) plus best supportive care (BSC)
Number of subjects: 68
Study 27584578 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care (BSC) alone
Number of subjects: 68
Study 26625989 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% subcutaneous lidocaine
Number of subjects: 60
Study 26625989 — intervention group
Group type: COMPARATOR
Intervention: Multimodal analgesia regime comprising systemic anti‐inflammatory agents and opioids
Number of subjects: 60
Study 23263241 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg/day
Number of subjects: 47
Study 23263241 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg/day
Number of subjects: 47
Study 20681960 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute stroke care in stroke units
Number of subjects: 687
Study 20681960 — intervention group
Group type: EXPERIMENTAL
Intervention: Surviving patients
Number of subjects: 687
Study 19134126 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium ascorbyl phosphate (SAP)
Number of subjects: 0
Study 19134126 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% retinol
Number of subjects: 0
Study 19134126 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 5% SAP and 0.2% retinol
Number of subjects: 0
Study 16786230 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-duration thromboprophylaxis with enoxaparin 40 mg subcutaneously once daily for an additional 28 +/- 4 days
Number of subjects: 4726
Study 16786230 — intervention group
Group type: COMPARATOR
Intervention: Standard regimen of enoxaparin 40 mg subcutaneously once daily for 10 +/- 4 days
Number of subjects: 4726
Study 16786230 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-duration thromboprophylaxis with enoxaparin
Number of subjects: 4726
Study 14745143 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 5 mg
Number of subjects: 2139
Study 14745143 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 2139
Study 14745143 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 2139
Study 14745143 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 20 mg
Number of subjects: 2139
Study 14745143 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 20 mg
Number of subjects: 2139
Study 14745143 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg
Number of subjects: 2139
Study 14745143 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 20 mg
Number of subjects: 2139
Study 11389491 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoperazone-sulbactam plus cotrimoxazole (cefoperazone 25 mg/kg/day, TMP-SMZ at a ratio of 80:400, TMP 8 mg/kg/day)
Number of subjects: 219
Study 11389491 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime plus cotrimoxazole (ceftazidime 100 mg/kg/day, TMP-SMZ at a ratio of 80:400, TMP 8 mg/kg/day)
Number of subjects: 219
Study 11389491 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment regimens
Number of subjects: 219
Study 8978577 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT (350 mg/m2/day orally x 14 days)
Number of subjects: 62
Study 8978577 — intervention group
Group type: COMPARATOR
Intervention: 5-FU (500 mg/m2 I.V. days 1 and 8)
Number of subjects: 62
Study 8978577 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT
Number of subjects: 62
Study 8978577 — intervention group
Group type: COMPARATOR
Intervention: 5-FU
Number of subjects: 62
Study 8440838 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Training (WT)
Number of subjects: 36
Study 8440838 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 36
Study 8440838 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Program Adherence
Number of subjects: 36
Study 3545719 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 28
Study 3545719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 3545719 — intervention group
Group type: COMPARATOR
Intervention: Atropine
Number of subjects: 28
Study 30297569 — intervention group
Group type: EXPERIMENTAL
Intervention: Cowpea fortified cookies (60:40 ratio of cowpea to wheat)
Number of subjects: 17
Study 30297569 — intervention group
Group type: COMPARATOR
Intervention: 100% wheat cookies (Control)
Number of subjects: 17
Study 27554441 — intervention group
Group type: EXPERIMENTAL
Intervention: G5 embryo culture medium
Number of subjects: 836
Study 27554441 — intervention group
Group type: COMPARATOR
Intervention: HTF embryo culture medium
Number of subjects: 836
Study 24519752 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous trastuzumab plus chemotherapy
Number of subjects: 0
Study 24519752 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 0
Study 22360924 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone alone
Number of subjects: 12
Study 22360924 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone plus orally administered 17 Beta estradiol
Number of subjects: 12
Study 22360924 — intervention group
Group type: COMPARATOR
Intervention: No luteal support
Number of subjects: 12
Study 20180606 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-pharmacist collaborative intervention
Number of subjects: 104
Study 20180606 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study 18538237 — intervention group
Group type: EXPERIMENTAL
Intervention: Quad-helix appliance
Number of subjects: 60
Study 18538237 — intervention group
Group type: EXPERIMENTAL
Intervention: Expansion plate
Number of subjects: 60
Study 18538237 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite onlay
Number of subjects: 60
Study 18538237 — intervention group
Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 60
Study 15944337 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (CaCO3), n = 14
Number of subjects: 29
Study 15944337 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer, n = 15
Number of subjects: 29
Study 11827233 — intervention group
Group type: EXPERIMENTAL
Intervention: Työhön Job Search Program
Number of subjects: 1261
Study 10075388 — intervention group
Group type: EXPERIMENTAL
Intervention: lisinopril
Number of subjects: 30
Study 10075388 — intervention group
Group type: EXPERIMENTAL
Intervention: nifedipine
Number of subjects: 30
Study 10075388 — intervention group
Group type: COMPARATOR
Intervention: healthy control subjects
Number of subjects: 30
Study 7491693 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 127
Study 7491693 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 127
Study 7491693 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 127
Study 7491693 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 127
Study 7491693 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 127
Study 7491693 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressive drugs
Number of subjects: 127
Study 7491693 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-rejection compliance scores
Number of subjects: 127
Study 2181950 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrogastrostomy
Number of subjects: 310
Study 2181950 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical gastroplasty
Number of subjects: 310
Study 2181950 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass
Number of subjects: 310
Study 1186568 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific hyposensibilisation
Number of subjects: 160
Study 1186568 — intervention group
Group type: COMPARATOR
Intervention: Avoidance measurements
Number of subjects: 160
Study 31251444 — intervention group
Group type: EXPERIMENTAL
Intervention: BTX 160 U
Number of subjects: 40
Study 31251444 — intervention group
Group type: EXPERIMENTAL
Intervention: BTX 200 U
Number of subjects: 40
Study 29231497 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding at bilateral Pishu (BL 20), Weiwanxiashu (EX‐B 3), Ganshu (BL 18), Shenshu (BL 23), and Zusanli (ST 36), once every 15 days for 6 times.
Number of subjects: 86
Study 29231497 — intervention group
Group type: COMPARATOR
Intervention: Control group received diabetes health education only.
Number of subjects: 86
Study 24215741 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich bone augmentation (SBA) technique
Number of subjects: 26
Study 24215741 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich bone augmentation (SBA) technique with critical crest angulation (CA) < 150°
Number of subjects: 26
Study 24215741 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich bone augmentation (SBA) technique with critical crest angulation (CA) > 150°
Number of subjects: 26
Study 23461841 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg glucophage po bid for 12 weeks
Number of subjects: 36
Study 23461841 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg magnesium oxide po bid for 12 weeks
Number of subjects: 36
Study 23461841 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg spironolactone po bid for 12 weeks
Number of subjects: 36
Study 22163272 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Cryotherapy (WBC)
Number of subjects: 9
Study 22163272 — intervention group
Group type: EXPERIMENTAL
Intervention: Far Infrared (FIR)
Number of subjects: 9
Study 22163272 — intervention group
Group type: COMPARATOR
Intervention: Passive (PAS)
Number of subjects: 9
Study 20155608 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-session motivational intervention
Number of subjects: 277
Study 20155608 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only condition
Number of subjects: 277
Study 16684023 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular (BiV) antitachycardia pacing (ATP)
Number of subjects: 400
Study 16684023 — intervention group
Group type: COMPARATOR
Intervention: Right ventricular (RV) antitachycardia pacing (ATP)
Number of subjects: 400
Study 15230484 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg AT-1015 BID
Number of subjects: 439
Study 15230484 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg AT-1015 BID
Number of subjects: 439
Study 15230484 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg AT-1015 BID
Number of subjects: 439
Study 15230484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 439
Study 11312478 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal atrial pacing in prone position
Number of subjects: 30
Study 11312478 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal atrial pacing in right lateral decubitus position
Number of subjects: 30
Study 11312478 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal atrial pacing in left lateral decubitus position
Number of subjects: 30
Study 11312478 — intervention group
Group type: COMPARATOR
Intervention: Transesophageal atrial pacing supine
Number of subjects: 30
Study 9386849 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment (n = 21)
Number of subjects: 29
Study 9386849 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) (n = 8)
Number of subjects: 29
Study 9386849 — intervention group
Group type: COMPARATOR
Intervention: Normal volunteers (control group, n = 14)
Number of subjects: 29
Study 7970064 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (parnaparin)
Number of subjects: 160
Study 7970064 — intervention group
Group type: COMPARATOR
Intervention: Calcium heparin
Number of subjects: 160
Study 3299090 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azidothymidine (AZT)
Number of subjects: 282
Study 3299090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study 29746726 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic candesartan 16 mg
Number of subjects: 42
Study 29746726 — intervention group
Group type: COMPARATOR
Intervention: Branded formulation
Number of subjects: 42
Study 27585757 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive treatment strategy (aiming for revascularisation within 7 days)
Number of subjects: 2457
Study 27585757 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invasive treatment strategy
Number of subjects: 2457
Study 25686142 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced arm (previous substance-using HIV/AIDS outreach workers)
Number of subjects: 94
Study 25686142 — intervention group
Group type: COMPARATOR
Intervention: Standard arm (CDPH personnel)
Number of subjects: 94
Study 23093339 — intervention group
Group type: EXPERIMENTAL
Intervention: Smooth soup
Number of subjects: 12
Study 23093339 — intervention group
Group type: EXPERIMENTAL
Intervention: Chunky soup
Number of subjects: 12
Study 23093339 — intervention group
Group type: COMPARATOR
Intervention: Solid meal
Number of subjects: 12
Study 20802322 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (10% solution of pentastarch)
Number of subjects: 262
Study 20802322 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 262
Study 18187744 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (20, 40, or 80 mg three times daily)
Number of subjects: 278
Study 18187744 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 278
Study 16439928 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Skills Program (LSK)
Number of subjects: 582
Study 16439928 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Cognitive Theory (SCT)
Number of subjects: 582
Study 16439928 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 582
Study 16439928 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers in SCT group
Number of subjects: 582
Study 16439928 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers overall
Number of subjects: 582
Study 15153584 — intervention group
Group type: EXPERIMENTAL
Intervention: Insole with dome pad design
Number of subjects: 10
Study 15153584 — intervention group
Group type: EXPERIMENTAL
Intervention: Insole with bar pad design
Number of subjects: 10
Study 15153584 — intervention group
Group type: COMPARATOR
Intervention: Shoe-only control condition
Number of subjects: 10
Study 11781759 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance subjects (n=322)
Number of subjects: 644
Study 11781759 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 644
Study 11781759 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline waist-hip ratio (WHR)
Number of subjects: 644
Study 11781759 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-load 2 h plasma glucose
Number of subjects: 644
Study 11781759 — intervention group
Group type: EXPERIMENTAL
Intervention: High baseline waist circumference or WHR (>= median)
Number of subjects: 644
Study 11781759 — intervention group
Group type: COMPARATOR
Intervention: Low waist circumference (< median)
Number of subjects: 644
Study 9407981 — intervention group
Group type: EXPERIMENTAL
Intervention: Fistulotomy
Number of subjects: 52
Study 9407981 — intervention group
Group type: COMPARATOR
Intervention: Incision and drainage (Control)
Number of subjects: 52
Study 8352673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 8352673 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine hydrochloride (20 mg)
Number of subjects: 16
Study 8352673 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (12.5 mg)
Number of subjects: 16
Study 8352673 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine hydrochloride (0.1 mg)
Number of subjects: 16
Study 8352673 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-treated group (overall)
Number of subjects: 16
Study 8352673 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (all patients)
Number of subjects: 16
Study 8352673 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (specific patients)
Number of subjects: 16
Study 3602599 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambroxol (30 mg tablet 3 times/day for adults; 9 mg syrup 4 times/day for children)
Number of subjects: 435
Study 3602599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 435
Study 31272404 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-led strategies informed by behavioral economics implemented in 6 weekly cooking skills classes
Number of subjects: 103
Study 31272404 — intervention group
Group type: COMPARATOR
Intervention: Vegetable cooking skills classes alone (Control)
Number of subjects: 103